BIM upregulation and ROS-dependent necroptosis mediate the antitumor effects of the HDACi Givinostat and Sorafenib in Hodgkin lymphoma cell line xenografts

Silvia L. Locatelli,Loredana Cleris,Giuliano Giuseppe Stirparo,Silvia Tartari,Elena Saba,Marina Pierdominici,Walter Malorni,Antonino Carbone,Andrea Anichini,Carmelo Carlo-Stella

BIM upregulation and ROS-dependent necroptosis mediate the antitumor effects of the HDACi Givinostat and Sorafenib in Hodgkin lymphoma cell line xenografts

2014

Silvia L. Locatelli
Loredana Cleris
Giuliano Giuseppe Stirparo
Silvia Tartari
Elena Saba
Marina Pierdominici
Walter Malorni
Antonino Carbone
Andrea Anichini
Carmelo Carlo-Stella

BIM upregulation and ROS-dependent necroptosis mediate the antitumor effects of the HDACi Givinostat and Sorafenib in Hodgkin lymphoma cell line xenografts

Keywords:

Cancer research
Lymphoma
Necroptosis
Immunology
Sorafenib
Downregulation and upregulation
Givinostat
Cell culture
Biology
hodgkin lymphoma

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations